jocelynhudson

41 POSTS 0 COMMENTS

New catheter system for His bundle pacing receives US FDA clearance

  Medtronic has announced US Food and Drug Administration (FDA) clearance and commercial launch for the SelectSite C304-HIS deflectable catheter system for use in procedures...

HRS 2019: MADIT trials analysis shows decline in sudden cardiac deaths...

Valentina Kutyifa (Rochester, USA) discusses the late-breaking study findings looking at data from the family of MADIT (Multicenter Automatic Defibrillator) trials. Kutyifa told Cardiac Rhythm...

HRS 2019: Next-gen cryoballoon ablation system provides “greater personalisation” to operators

Ante Anic (Split, Croatia) discusses the first in-human trial (CRYO-FIM) looking at a novel cryoballoon ablation system for pulmonary vein isolation at HRS 2019...

REAFFIRM trial data show no significant difference between rotor ablation and...

Johannes Brachmann (Coburg, Germany) speaks to Cardiac Rhythm News at HRS 2019 about the REAFFIRM trial, which compared the use of rotor ablation versus...

Boston Scientific initiates trial comparing left atrial appendage closure to direct...

According to a press release, Boston Scientific has initiated the OPTION trial to compare safety and effectiveness of the next-generation Watchman FLX left atrial...

UNTOUCHED finds high conversion efficacy and low adverse event rate for...

The Emblem subcutaneous implantable defibrillator system (S-ICD; Boston Scientific) demonstrated a high conversion efficacy and low adverse event rate. Data from the UNTOUCHED trial...

Results announced from study with the HeartLight X3 system

CardioFocus recently announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 system for the treatment of AFib. The results...

HRS 2019: Ear clip uses neurostimulation to effectively reduce AFib burden

A trial evaluating Parasym’s neurostimulation technology shows that an ear-clip-like device can help reduce atrial fibrillation burden. The results were presented at the Heart...

Low referral rates and treatment disparities lead to underuse of ICDs...

Implantable cardiac devices are underused, with widespread gender and race treatment disparities, and low referral rates to electrophysiologists, according to the findings from three...

A cardiologist’s clinical experience with BIOTRONIK’s Acticor/Rivacor* ICDs and CRT-Ds

This advertorial has been sponsored by BIOTRONIK Dr. Victor Sanfins is a cardiologist at Hospital da Senkora da Oliveira in Guimarães, Portugal, and a specialist...

US physicians now treating patients with Biotronik’s Acticor DX devices

Biotronik recently announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the USA are...

Acutus Medical’s new contact mapping software receives CE mark

Acutus Medical recently announced CE mark approval for AcQMap contact mapping software, offering expanded functionality that provides physicians with more options to inform individualised...

Randomised controlled trial finds that efficacy is not compromised by using...

In a late-breaking session at the European Heart Rhythm Association annual congress (EHRA; 17–19 March, Lisbon, Portugal), Jason Andrade of Vancouver, Canada presented the...

High power short duration ablation for atrial fibrillation: Safety and effectiveness

As part of a session on novel mapping and ablation technologies of atrial fibrillation (AF) at the recent AF Symposium in Boston, USA (24–26...

Is CABANA a positive or negative trial?

Several treatment options are available for atrial fibrillation (AF), including pharmacological rate or rhythm control, and catheter or surgical ablation. However, consensus as to...

TYRX envelope “significantly reduced” major CIED infection in worldwide randomised trial

Bruce Wilkoff (Cleveland Clinic, Cleveland, USA) presented results of the worldwide randomised antibiotic envelope infection prevention trial (WRAP-IT) to reduce CIED infection at the...

Late-breaking trial highlights positive safety and efficacy data for the LUMINIZE...

Boston Scientific announced data from the AF-FICIENT I study during a late-breaking clinical trial session at the 2019 European Heart Rhythm Association annual congress...

Results of the CIRCA-DOSE study presented at EHRA 2019

In a late-breaking session at the 2019 European Heart Rhythm Association annual congress (EHRA; 17–19 March, Lisbon, Portugal), Jason Guy Andrade of Vancouver, Canada...

CE mark for Watchman FLX left atrial appendage closure device

Boston Scientific announced it has received CE mark and initiated a limited market release of the next generation Watchman FLX left atrial appendage closure...

Biotronik launches 3 Tesla full-body MR conditional ICD and CRT-D devices...

Biotronik today announced the European market release of the world’s smallest implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) that are approved for...

Mapping dynamic patterns during atrial fibrillation can produce higher success rates

In a late breaking session at the 2019 AF Symposium in Boston, USA (24–26 January), it was announced that a dipole density (DD) mapping...

New Australian research and development partnership aims to innovate heart failure...

Biotronik, the University of Newcastle (Callaghan, Australia) and the Hunter New England Local Health District (HNE LHD) have partnered to shape a heart failure care model. To...

First AF patient treated in US IDE study evaluating QDot Micro...

It was recently announced that Biosense Webster has enrolled and treated the first patient in its US Investigational Device Exemption (IDE) study, which evaluates...

Bardy Diagnostics announces expansion into Canadian market

It was announced recently that Bardy Diagnostics (BardyDx) has entered into a distribution agreement with JNC Medical, a distributor of medical technologies based in...

More than 40% of patients with a history of atrial fibrillation...

Patients with a previous diagnosis of atrial fibrillation who were assessed as attending the emergency department inappropriately did so because of fear, or as...

Combining practical and scientific learning to meet educational needs at Europe’s...

Sabine Ernst and Mattias Duytschaever are both consultant cardiologists and scientific committee members of the practical and scientific faculty of the Atrial Fibrillation Symposium,...

Patients with atrial fibrillation who are frail or have cognitive impairment...

Malini Madhavan (Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA) and others reported the results of a study in American Heart Journal that found...

More research needed to justify continued use of wearable cardioverter defibrillator...

Ahmad Masri (Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA) and others report in JACC: Clinical Electrophysiology that a systematic...

Use of a radiation safety time out reduces radiation exposure during...

A study carried out at the New York University Langone Health Electrophysiology Lab (New York, USA) showed significantly reduced radiation exposure levels after implementing...

New financing to commercialise Globe system for treatment of atrial fibrillation

In a new financing round, Kardium has raised an undisclosed amount to fund commercial activities in Europe and Canada, and for clinical testing of the Globe...

First patient enrolled in ICE-AFIB clinical trial

A press release reports that the first patient has been enrolled in the ICE-AFIB clinical trial (AtriCure). Following Investigational Device Exemption (IDE) approval by...

Top 10 takeaways – the need to increase focus and awareness...

A new report from Biosense Webster sets out the scale and impact of atrial fibrillation (AF) across Europe and calls for greater awareness and...

New AHA treatment guidelines for use of blood thinners with atrial...

A newer type of blood-thinning medications, non-vitamin K oral anticoagulants (NOACs), is now recommended as the preferred alternative to warfarin for reducing the risk...

Cardiac Rhythm News Issue 43 — January 2019

Highlights: "No serious adverse outcomes" with ICD shocks in young athletes playing sport Computerised-decision support has the potential to be a "powerful tool" for...

Medtronic to acquire EPIX Therapeutics

Medtronic has announced that it has entered into a definitive agreement to acquire EPIX Therapeutics. When completed, the EPIX acquisition will expand the Medtronic...

The link between atrial fibrillation and obstructive sleep apnoea

Obstructive sleep apnoea and atrial fibrillation (AF) have presented many challenges, including identifying which patients need to be assessed for obstructive sleep apnoea and...

Prevent POAF by simultaneous monitoring of autonomic tone and ectopic activity

Simultaneous monitoring of autonomic tone and ectopic activity could be used to prevent the occurrence of postoperative atrial fibrillation (POAF). Flavia Ravelli (Department of...

First AI-driven wearable heart monitor that prevents heart disease and stroke...

Cambridge Heartwear is announcing the launch of their company and release of their Heartsense monitor in 2019. In the US, strokes are among the...

Bardy Diagnostics achieves milestone of 40,000 patients monitored by the Carnation...

It has been announced that Bardy Diagnostics has monitored over 40,000 patients driven by rapid adoption of the Carnation Ambulatory Monitor (CAM), the world's...

FDA approval granted for VASCADE MVP system

Premarket Approval (PMA) from the US Food and Drug Administration (FDA) has been granted for the VASCADE MVP Venous Vascular Closure System (Cardiva Medical)....

First patient treated in TERMINATE AF clinical trial

The first patient has been treated in the TERMINATE AF trial (Medtronic). This is a multi-centre study evaluating two surgical ablation devices—the Cardioblate irrigated...